Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Zulresso Approved as First Treatment for Postpartum Depression
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
FDA to Review Lemborexant NDA for Treatment of Insomnia
Conversion From Sleep Disorder to Neurodegeneration Studied
Rapastinel Fails to Meet Primary Endpoint in Phase 3 Adjunctive MDD Trials
Spravato Nasal Spray Approved for Treatment-Resistant Depression
Can a Physician Be Held Liable When a Patient Commits Suicide?
MMR Not Linked to Autism in Danish Cohort Study
Adhansia XR Approved for the Treatment of Pediatric, Adult ADHD
Does Montelukast Increase the Risk for Neuropsychiatric Disease?
Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk
Sertraline Tops CBT for Reducing Depression in Dialysis Patients
Allergy Associated With Mental Health Disorders in Pregnant Women
DEA Tool Helps Drug Manufacturers, Distributors Identify Suspicious Opioid Orders
Some Characteristics Unique to Depression Before, After Birth
Results From Bipolar I Disorder Trials Evaluating Brexpiprazole Announced
FDA to Review Pitolisant for Narcolepsy Treatment
FDA Committees Vote on Esketamine Nasal Spray for Treatment-Resistant Depression
